GVAX (GMCSF gene modified tumor vaccine) in advanced stage non small cell lung cancer.
about
MHC II lung cancer vaccines prime and boost tumor-specific CD4+ T cells that cross-react with multiple histologic subtypes of nonsmall cell lung cancer cells.Gene therapy for cancer treatment: past, present and futureRespiratory Homeostasis and Exploitation of the Immune System for Lung Cancer VaccinesNovel targeted agents in the treatment of lung cancer.Liver myeloid-derived suppressor cells expand in response to liver metastases in mice and inhibit the anti-tumor efficacy of anti-CEA CAR-TVaccines in cancer: GVAX, a GM-CSF gene vaccine.Clinical trials targeting lung cancer with active immunotherapy: the scope of vaccines.Adenovirus as vehicle for anticancer genetic immunotherapy.Immune cell recruitment and cell-based system for cancer therapy.DNA-mediated adjuvant immunotherapy extends survival in two different mouse models of myeloid malignanciesPresent and future of lung cancer vaccines.The IL-17-Th1/Th17 pathway: an attractive target for lung cancer therapy?Tumor-associated GM-CSF overexpression induces immunoinhibitory molecules via STAT3 in myeloid-suppressor cells infiltrating liver metastases.IL-12 immunotherapy of murine leukaemia: comparison of systemic versus gene modified cell therapy.Increased in vitro Cell Proliferation by Chitosan/pGM-CSF Complexes
P2860
Q34161849-8DF4B012-1A4A-4F38-A9B0-22C34B3BD934Q35040146-CB5CED6F-52B4-473F-886C-6210A851F224Q35774908-7ECD3ABD-FFCE-4301-8891-B4A0D80E4BAEQ35790783-BE10B12D-B523-4402-9674-37EEFD06FD2DQ35798161-393AFDCA-CE4A-4E26-B739-0E7942E3CAEAQ36198632-8AC8914C-A664-4700-9C6F-46C13F77728DQ36235551-7B32337D-DCB7-44BA-A526-F1764330DC74Q36288930-EE73EE5C-E853-4DD8-A19D-9EE03C5FB052Q36517706-70346598-C33B-477D-A2AA-AF74D2870ED4Q36544893-15092736-7859-4656-B8C4-EFFBAEC252EEQ36580586-2447EB60-DA2A-4004-8250-9863B21D5D8EQ38879975-6ED33D88-6254-4575-BDB2-23FA451E5120Q39751334-217A3300-9C7E-44DA-A67D-8AB3035E4783Q39961838-E8E1D326-B322-440D-B289-B97FC6DD10DDQ40695620-CE8414B7-E3E8-4BCD-96ED-7380E6B87B7F
P2860
GVAX (GMCSF gene modified tumor vaccine) in advanced stage non small cell lung cancer.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
GVAX (GMCSF gene modified tumor vaccine) in advanced stage non small cell lung cancer.
@ast
GVAX (GMCSF gene modified tumor vaccine) in advanced stage non small cell lung cancer.
@en
type
label
GVAX (GMCSF gene modified tumor vaccine) in advanced stage non small cell lung cancer.
@ast
GVAX (GMCSF gene modified tumor vaccine) in advanced stage non small cell lung cancer.
@en
prefLabel
GVAX (GMCSF gene modified tumor vaccine) in advanced stage non small cell lung cancer.
@ast
GVAX (GMCSF gene modified tumor vaccine) in advanced stage non small cell lung cancer.
@en
P1476
GVAX (GMCSF gene modified tumor vaccine) in advanced stage non small cell lung cancer.
@en
P2093
John Nemunaitis
P304
P356
10.1016/S0168-3659(03)00210-4
P407
P577
2003-08-01T00:00:00Z